Ubqln1 displays anti-apoptotic potential in lung cancer cells by stabilizing Bcl-B, a Bcl-2 family protein [11]; Ubqln2 increases p53 levels by interfering with ubiquitin-mediated degradation of p53 in a UBA domain-dependent manner [4, 9]. The gene discussed is UBQLN1; the disease is lung cancer.